G Caleb Alexander
6PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.Brian J Mog, Nikita Marcou, Sarah R DiNapoli
|Mar 02, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.Suman Paul, Alexander H Pearlman, Jacqueline Douglass
|Mar 02, 2021
Targeting a neoantigen derived from a common <i>TP53</i> mutation.Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass
|Mar 02, 2021
Bispecific antibodies targeting mutant <i>RAS</i> neoantigens.Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog
|Mar 03, 2020
Estimated costs of pivotal trials for U.S. Food and Drug Administration-approved cancer drugs, 2015-2017.Emily Han-Chung Hsiue, Thomas J Moore, G Caleb Alexander
|Sep 19, 2019
Direct Detection and Quantification of Neoantigens.Qing Wang, Jacqueline Douglass, Michael S Hwang
Pageof 1
Frequent Collaborators
4 joint publications
Jacqueline Douglass
4 joint publications
Brian J Mog
4 joint publications
Sarah R DiNapoli
4 joint publications
Alexander H Pearlman
4 joint publications
Katharine M Wright
4 joint publications
Nickolas Papadopoulos
4 joint publications
Drew M Pardoll
4 joint publications
Suman Paul
4 joint publications
Chetan Bettegowda
4 joint publications
Maximilian F Konig
